Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1U10
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,832
Award facts
- Contract value 100% obligated
- $37,831.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $37,831.71 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Dupixent 300 mg/2 mL pen injectors. This non-set-aside, firm fixed-price contract will be completed by January 13, 2026, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic dermatitis, and certain asthma conditions, making this delivery critical to military and federal healthcare operations.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031. The IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, enabling efficient procurement of specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. AmerisourceBergen's demonstrated capability in federal pharmaceutical procurement, combined with its established position as a prime vendor for the Defense Health Agency and other government healthcare systems, positions the company as a key supplier for military medical requirements.
Quick answers
Who was awarded contract SPE2DR26F1U10?
SPE2DR26F1U10 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F1U10 worth?
The government has obligated $37,832 on SPE2DR26F1U10.
Is contract SPE2DR26F1U10 an order under another contract?
Yes. SPE2DR26F1U10 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1U10 competed?
The extent of competition for SPE2DR26F1U10 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award